Leicester’s Hospitals vascular service has successfully completed its integration onto one site with the re-location of some services from the Leicester Royal Infirmary (LRI) to the Glenfield Hospital. The departmental move is part of a £13.2m major equipment upgrade provided through the Trust’s vendor-independent managed service contract.
The project formed part of a development plan that includes a state-of-the-art hybrid theatre facility that has been purpose built as well as the re-location of a number of items of diagnostic imaging equipment. The hybrid theatre consists of three ultramodern pieces of equipment provided on a vendor-neutral basis with the support, knowledge and expertise of Althea’s Implementation and Technology team: a Siemens Axiom Artis Zeego; a GE Healthcare MacLab; and a Medrad Mark 7 Arterion injector. The new equipment has enhanced the department’s ability to undertake increasingly complex activity, has improved patient pathways and reduced clinical risk. Ultimately the project has assisted the clinical team provide the most comprehensive integrated vascular, cardiology and cardiac surgery services required to provide the best possible care to patients who are suffering with cardiovascular illnesses. Althea provided complete project support for the redesign of the department, from design, through build, to equipment installation.
Vascular disease is a class of diseases of the blood vessels – the arteries and veins of the circulatory system of the body. It is a subgroup of cardiovascular disease. Disorders in this vast network of blood vessels can cause a range of health problems which can be severe and often fatal, which is why it is important for the hospitals to have the most advanced technology available. Althea’s vendor-independence allowed Leicester’s Hospitals to exploit the mix of different systems available and identify the best fit for its patient needs.
Mark McCarthy, Consultant Vascular Surgeon and Head of Service at the Trust, explains: “This new investment in a hybrid theatre will enhance the care given to patients and will allow treatment of complex cardiovascular disease to be undertaken in a state-of-the-art operating theatre.”
Improving patient experience with these advancements in technology, the new hybrid theatre facility also offers new training opportunities to the staff in the hospital, in particular for the Imaging Team, as this is the first hybrid imaging equipment within Leicester’s Hospitals.
The new angiography suite has been designed to provide a tailor-made environment for the treatment and imaging of vascular patients. The suite, which includes a Mallinckrodt Angiomat Illumena and a Toshiba Infinix, both transferred from LRI, has its own day-case unit which enables the Imaging Team to provide more patient-centred care. The suite is also located close to the vascular ward which will contribute towards improved collaboration with the Imaging Team. The Imaging Team have also been working on various projects to improve documentation and patient preparation to in turn improve patient flow.
The new vascular studies unit is based on Level 1 and offers a dedicated patient reception, waiting area and two comfortable and spacious scanning rooms. A GE Logiq S8 and a GE Logiq E9 were both relocated from LRI. The units are located adjacent to the vascular ward, angiography suite and MDT room, enabling rapid access for the assessment of vascular in-patients as well as patients admitted to the unit. Overall, the move will improve work flow and facilitate collaborative working between departments involved in the care of vascular and cardiovascular patients.
Althea’s Implementation Manager, Lloyd Stewart, commented: “For the re-location, we ensured that the original equipment manufacturers were fully engaged to assist with the design and construction phases. The re-location was planned to minimise downtime so as not to impact on the interventional service at the Leicester Royal Infirmary and be ready to meet the opening of the new service at the Glenfield Hospital.”
Althea’s Head of Implementation & Technology, Andy Jones, commented: “The hybrid lab was a first for Althea and as recognised by all suppliers, these modalities are the most challenging projects to co-ordinate due to the high number of contractors and sub-contractors that need to be involved. With our support the Trust selected Siemens as the main equipment supplier along with GE for the Haemodynamic monitoring and Bayer/Medrad for the injector. Our main implementation task was to ensure all stakeholders had the required input through all phases of design and build while integrating key dates for the equipment delivery, installation and training programmes. Our implementation expertise ensured all equipment was installed and commissioned on time with minimal disruption to hospital operations.”